Last reviewed · How we verify
NCT07265856: VReducationRCT
The Effect of a Comprehensive Dementia Education Program on Improving Attitudes Toward People Living With Dementia
NA trial testing Comprehensive VR Program in Dementia in 200 participants. Enrolling by invitation.
30 January 2026
Quick facts
| Lead sponsor | Universitas Airlangga |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 1 October 2025 |
| Primary completion | 30 January 2026 |
| Estimated completion | 30 May 2026 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Comprehensive VR Program
- Conventional Lecture Program (Non-VR)
Conditions studied
- Dementia — all drugs for Dementia →
Sponsor
Universitas Airlangga — full company profile →
Who can join
Eligibility, any sex, with Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled trial focuses on Indonesian nursing students and examines the effectiveness of virtual reality (VR) dementia education programs. The study addresses the following research questions: 1. What is the current level of knowledge and awareness about dementia among participants before they engage in a VR dementia education program? 2. What is the effect of a VR dementia education program on improving participants' attitudes, knowledge, and intention to help people living with dementia, and how satisfied are participants with the VR education program? Participants will voluntarily join a 100-minute class session, with each participant attending only once. Participants are individually randomized into either the intervention group or the control group. The program is integrated into the faculty's dementia-related courses and includes several components: introduction, pre-program questionnaire, lecture, undesirable drama (unfriendly communication), undesirable VR experience, discussion, Lecture 1 (dementia overview), desirable VR experience, desirable drama, Lecture 2, N-impro, post-program questionnaire, and conclusion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07265856
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dementia
Currently open trials in the same condition.
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
- NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
- NCT06088810 — The Impact of Music Intervention on Sleep · NA · recruiting
- NCT07482800 — Dementia in Fiction and Clinical Narratives · recruiting
- NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
Other Universitas Airlangga trials
Trials by the same sponsor.
- NCT07418762 — Community-Based Program Integrating Nurse-Led Mind-Body Exercise and Nutrition for Frailty · NA · not yet recruiting
- NCT07238439 — Scenario-Driven Virtual Reality Game for Dementia Education Program · NA · enrolling by invitation
- NCT06629844 — Enhancing Healthcare Students' Attitudes Toward Dementia Care Through Virtual Reality Education · NA · completed
- NCT06160765 — The Efficacy of High Density Formula 1.5 kcal/ml or 1 kcal/ml On Catch Up Growth In Growth Faltering Children · completed
- NCT06122623 — Education Program for Enhancing Healthcare Students' Attitudes Toward People Living With Dementia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07265856 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitas Airlangga
- Last refreshed: 5 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07265856.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing